Related Experiment Video

Updated: May 20, 2026

Tumor Allotransplantation in Drosophila melanogaster with a Programmable Auto-Nanoliter Injector
05:06

Tumor Allotransplantation in Drosophila melanogaster with a Programmable Auto-Nanoliter Injector

Published on: February 2, 2021

JNK and PTEN cooperatively control the development of invasive adenocarcinoma of the prostate

Anette Hübner1, David J Mulholland, Claire L Standen

  • 1University of Massachusetts Medical School, Worcester, MA 01605, USA.

Proceedings of the National Academy of Sciences of the United States of America
|July 4, 2012
PubMed

Insights

The c-Jun NH(2)-terminal kinase (JNK) pathway suppresses prostate cancer progression. JNK deficiency accelerates the development of invasive, metastatic prostate adenocarcinoma by promoting progenitor cell expansion and proliferation.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • The c-Jun NH(2)-terminal kinase (JNK) signaling pathway is recognized for its involvement in various cancers, yet its precise role in tumorigenesis remains unclear.
  • Prostate cancer progression is often linked to dysregulation of signaling pathways, including those involving JNK and phosphatase and tensin homolog (PTEN).

Purpose of the Study:

  • To investigate the role of the JNK signaling pathway in the development and progression of prostate cancer.
  • To elucidate the interplay between JNK and PTEN signaling in regulating prostate neoplasia and adenocarcinoma development.

Main Methods:

  • Utilizing a conditional deletion model of PTEN in mice to study prostate cancer.
  • Generating mice with JNK deficiency or inhibited JNK activation in the prostate epithelium.
  • Analyzing tumor development, metastasis, progenitor cell populations, proliferation, and tumorigenic potential in genetically modified mouse models.

Main Results:

  • JNK deficiency in prostate epithelium accelerates the development of androgen-independent metastatic prostate cancer in PTEN-deficient mice.
  • Inhibition of JNK activation in the prostate epithelium leads to rapid invasive adenocarcinoma.
  • JNK signaling defects result in androgen-independent expansion of immature progenitor cells with increased proliferation and tumorigenic potential.

Conclusions:

  • The JNK signaling pathway acts as a suppressor of invasive adenocarcinoma development in the context of PTEN loss.
  • JNK and PTEN signaling pathways cooperate to regulate the progression of prostate neoplasia to invasive adenocarcinoma.
  • Targeting JNK signaling may offer therapeutic strategies for aggressive prostate cancer with PTEN deficiency.

More Related Videos

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...